FreeGulliver LLC’s Abbott ABT Stock Holding History

FreeGulliver LLC’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,552	Closed	-$208K	–	107
2025 Q3	$208K	Buy	+1,552	New	+$204K	0.09%	86
2024 Q4	–	Sell	-2,030	Closed	-$231K	–	94
2024 Q3	$231K	Sell	2,030 -885	-30%	-$97.1K	0.14%	72
2024 Q2	$303K	Buy	2,915 +415	+17%	+$44K	0.21%	49
2024 Q1	$284K	Buy	+2,500	New	+$287K	0.25%	46

Other funds holding ABT

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FreeGulliver LLC's ABT Position: Q4 2025 in Review

FreeGulliver LLC sold out of Abbott (ABT) in Q4 2025, closing a stake of 1,552 shares — an estimated $208K sold.

FreeGulliver LLC first reported a position in ABT in Q1 2024 and held it in 4 quarters. The position peaked at $303K in Q2 2024. 3,275 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

FreeGulliver LLC reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
FreeGulliver LLC sold 1,552 Abbott shares in Q4 2025, an estimated $208K.
FreeGulliver LLC first reported a position in Abbott in Q1 2024 and held it in 4 quarters.
FreeGulliver LLC's Abbott position peaked at $303K in Q2 2024.
3,275 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on FreeGulliver LLC's 13F filing for Q4 2025, filed 12 Feb 2026.